The genus Enterobacter is a member of the ESKAPE group, which contains the major
resistant bacterial pathogens. First described in 1960, this group member has proven to be …

The rise of antibiotic resistance and a dwindling antimicrobial pipeline have been
recognized as emerging threats to public health. The ESKAPE pathogens—Enterococcus …

Immediately after birth, newborn babies experience rapid colonization by microorganisms
from their mothers and the surrounding environment. Diseases in childhood and later in life …

Species within the Enterobacter cloacae complex (ECC) include globally important
nosocomial pathogens. A three-year study of ECC in Germany identified Enterobacter …

Recent reports have established the escalating threat of carbapenem-resistant Enterobacter
cloacae complex (CREC). Here, we demonstrate that CREC has evolved as a highly …

Background Hospital outbreaks of carbapenemase-producing organisms, such as bla IMP-4-
containing organisms, are an increasing threat to patient safety. Objectives To investigate …

Systemic antibiotic therapy is the main treatment for acute bacterial rhinosinusitis (ABRS).
However, this treatment often causes side effects of dizziness, diarrhea, and drug resistance …

Enterobacter cloacae complex (ECC) is composed of multiple species and the taxonomic
status is consecutively updated. In last decades ECC is frequently associated with multidrug …

Objectives To investigate the population structure, drug resistance mechanisms and
plasmids of community-associated Enterobacter cloacae complex (CA-ECC) isolates in …

The emergence and spread of antibiotic‐resistant Gram‐negative bacteria (rGNB) across
global healthcare networks presents a significant threat to public health. As the number of …